AUTHORS
Svatava Merkle, MD, Lubna Hamdan, MD2, Jennifer Korpik3, Punam Malik, MD4, Maria Carter Febres, MD5, Luke R. Smart, MD6, Theodosia M Kalfa Jr, MD, PhD7
AFFILIATIONS
1 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
2 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
3 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
4 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
5 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
6 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
7 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
ABSTRACT
Infantile pyknocytosis (IP) is a rare DAT-negative hemolytic anemia of infancy. Its population prevalence is unknown; however, a retrospective series reported IP in 14 of 149 (9.4%) infants evaluated for unexplained neonatal hemolytic anemia (HA) (Eyssette‐Guerreau et al, BJH 2006). Although first described as early as in 1959 (Tuffy, A.M.A. J. Dis. Child. 1959), the etiology of this disease remains unclear. Patients typically present within the first few weeks of life with severe HA, often leading to neonatal hyperbilirubinemia that may require phototherapy, simple- or exchange transfusions. Notably, the prognosis is excellent and disease self-resolves overtime (Drouilly et al, PBC 2024). Patients frequently undergo extensive work-up prior to establishing the diagnosis, given severe presentation, and no established laboratory diagnostic method currently available for IP. Osmotic gradient ektacytometry (OGE) could be a useful diagnostic tool for early recognition of infants with IP.
We identified a cohort of 8 patients with the diagnosis of IP in a single referral center. Clinical data was extracted from the electronic medical record. Osmotic gradient ektacytometry (LoRRca MexSis, RR Mechatronics, Zwaag, Netherlands) was used to evaluate erythrocytes under rotational force while subjected to an osmolar gradient (OsmoScan).
Consistent with previous report, family clustering was noted including 2 sibling pairs. Five patients in our cohort were male and six were born at term. Jaundice, indicating ongoing hemolysis, was present at birth in 5 patients and as late as 2 weeks of age in 1 patient. The hemoglobin nadir mean in our cohort was 7,4 gm/dL (range 6.1 – 9.8). Seven patients required transfusions and six patients phototherapy. Median age of resolution of anemia was 1.5 months (range 1-3 months). All patients had osmotic gradient ektacytometry performed as part of their diagnostic work-up.
Contrary to previous reports suggesting normal ektacytometry results in patients with IP, although with no data shown (Eyssette‐Guerreau et al, BJH 2006, Vos et al, Eur. J. Pediatr. 2014, Bobée et al, Blood 2020, Drouilly et al, PBC 2024), we observed a trapezoid shape, a consistent decrease in Elmax (mean 0.570; SD±0.012; normal range 0.595-0.625), and Ohyp on the lower range of normal (mean 438; SD±9; normal range 435-491) compared to controls with similar ages. EImax is the maximum elongation index that corresponds to the maximum deformability of the red cells under shear stress; decreased EImax indicates impaired red cell deformability in agreement to the presence of rigid pyknocytes. Ohyp characterizes the declining portion of the curve and is defined as the osmolality value where the cells are at half of the maximum elongation. It correlates with the initial MCHC (intracellular viscosity) of the cell sample (Mohandas et al, JCI 1980). The left-shifted (decreased) Ohyp along a narrow, compressed curve, which we see in IP, reflects the cellular dehydration of a significant fraction of the erythrocytes. Omin, the value of hypotonic osmolality where deformability is the lowest, that provides information on the initial surface-to-volume ratio of the cell sample was low, as it is typically in neonates, or low-normal (mean 135; SD±9; normal range 136-158).
This ektacytometry curve is not seen in any of the hereditary red cell membrane disorders and corresponds to the unique combination of morphologies seen on the blood smear in infants with IP. The management of IP needs to be prompt to prevent complications of neonatal hyperbilirubinemia and/or anemia, similarly to the management of chronic hereditary hemolytic anemias, which tend to present in an aggravated manner in infancy. Nevertheless, incorporating osmotic gradient ektacytometry before first transfusion in the diagnostic work-up can significantly decrease the anxiety of the family and caretakers with awareness of infantile pyknocytosis as the likely diagnosis, and decrease need for further expensive diagnostic testing.
DISCLOSURES
Svatava Merkle, MD: Amgen - Stock (publicly traded); CRISPR - Stock (publicly traded); Eli Lilly - Stock (publicly traded); Roche - Stock (publicly traded); Novartis - Stock (publicly traded); Vertex - Stock (publicly traded); Siemens AG - Stock (publicly traded)